Presentation AGM26 March 2026

‌Welcome

Annual General Meeting of Carl Zeiss Meditec AG

Thursday, March 26, 2026

million Euro revenue in fiscal year 2024/25

Mio. Euro EBITA* in fiscal year 2024/25

+4%

EBITA*-margin in fiscal year 2024/25

*Earnings before interest, taxes and amortization of intangible assets from the purchase price allocation

million euros in revenue in the first quarter of 2025/26

compared to the previous year

mio. euros in EBITA

‌CIRRUS®PathFinderTM

AI-based deep learning tool supports OCT interpretation in ophthalmic diagnostics

CONVIVO®In Vivo Pathology Suite

Provides real-time information on tissue microstructure through consultations based on digital images

‌Our commercial strategy focuses on delivering value to customers worldwide:

We understand local needs, develop tailored offerings, and scale them efficiently - to drive sustainable growth and build long-term customer relationships.

Magnus Reibenspiess Chief Commercial Officer

‌KINEVO®900 S

Further development of the successful ZEISS KINEVO 900 platform

PENTERO®800 S

ZEISS PENTERO platform redesigned for the digital world

‌ILM-Blue®by DORC

Vital dye for staining the inner limiting membrane of the retina

Dr. Ananth Sastry, MD, Cleveland Clinic, Ohio

‌AT LISA®809

In February 2026, ZEISS received a license in China for the new model of this bifocal intraocular lens.

‌©Deutscher Zukunftspreis / Ansgar Pudenz

©Deutscher Zukunftspreis / Ansgar Pudenz

ZEISS EUV Lithographie

Winner of

Deutscher Zukunftspreis 2020

ZEISS KINEVO 900

Circle of the Best

Deutscher Zukunftspreis 2020

‌©Deutscher Zukunftspreis / Ansgar Pudenz

©Deutscher Zukunftspreis / Ansgar Pudenz

ZEISS Lattice Lightsheet 7

Winner of

Deutschen Zukunftspreis 2022

ZEISS VisuMax & ZEISS SMILE

Circle of the Best

Deutschen Zukunftspreis 2025

Euro dividend per share